Global Reproductive Genetics Market By Procedure Type-(Pre-Natal Screening, Pre-Implantation Genetic Testing, Infertility Genetic Testing, Carrier Screening) By Product Type-(Kits, Laboratory Developed Tests (LDT), Reagents and Consumables) By Application-(Aneuploidy, Single Gene Disorder, Structural Chromosomal Abnormality, Other Applications) By Technology-(PCR, Next-Generation Sequencing, In-Situ Hybridization (ISH), Microarray) and by Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Feb 2024
- Report ID: 84850
- Number of Pages: 340
- Format:
- keyboard_arrow_up
- 1. Executive Summary
- 1.1. Definition
- 1.2. Taxonomy
- 1.3. Research Scope
- 1.4. Key Analysis
- 1.5. Key Findings by Major Segments
- 1.6. Top strategies by Major Players
- 2. North America & Europe Reproductive Genetics Overview
- 2.1. Reproductive Genetics Dynamics
- 2.1.1. Drivers
- 2.1.2. Opportunities
- 2.1.3. Restraints
- 2.1.4. Challenges
- 2.2. Macro-economic Factors
- 2.3. Regulatory Framework
- 2.4. Market Investment Feasibility Index
- 2.5. PEST Analysis
- 2.6. PORTER’S Five Force Analysis
- 2.7. Drivers & Restraints Impact Analysis
- 2.8. Industry Chain Analysis
- 2.9. Cost Structure Analysis
- 2.10. Marketing Strategy
- 2.11. Russia-Ukraine War Impact Analysis
- 2.12. Opportunity Map Analysis
- 2.13. Market Competition Scenario Analysis
- 2.14. Product Life Cycle Analysis
- 2.15. Opportunity Orbits
- 2.16. Manufacturer Intensity Map
- 2.17. Major Companies' sales by Value & Volume
- 2.1. Reproductive Genetics Dynamics
- 3. North America & Europe Reproductive Genetics Analysis, Opportunity and Forecast, 2016-2032
- 3.1. North America & Europe Reproductive Genetics Analysis, 2016-2021
- 3.2. North America & Europe Reproductive Genetics Opportunity and Forecast, 2023-2032
- 3.3. North America & Europe Reproductive Genetics Analysis, Opportunity and Forecast, By Procedure Type, 2016-2032
- 3.3.1. North America & Europe Reproductive Genetics Analysis by Procedure Type: Introduction
- 3.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Procedure Type, 2016-2032
- 3.3.3. Carrier Screening
- 3.3.3.1. Carrier Screening1
- 3.3.3.2. Carrier Screening2
- 3.3.4. Pre-Natal Screening
- 3.3.5. Pre-Implantation Genetic Testing
- 3.3.6. Infertility Genetic Testing
- 3.4. North America & Europe Reproductive Genetics Analysis, Opportunity and Forecast, By Product Type, 2016-2032
- 3.4.1. North America & Europe Reproductive Genetics Analysis by Product Type: Introduction
- 3.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product Type, 2016-2032
- 3.4.3. Kits
- 3.4.4. Laboratory Developed Tests
- 3.4.5. Reagents & Consumables
- 3.5. North America & Europe Reproductive Genetics Analysis, Opportunity and Forecast, By Technology, 2016-2032
- 3.5.1. North America & Europe Reproductive Genetics Analysis by Technology: Introduction
- 3.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Technology, 2016-2032
- 3.5.3. Next Generation Sequencing
- 3.5.4. Polymerase Chain Reaction
- 3.5.5. In-Situ Hybridization
- 3.5.6. Microarray
- 3.6. North America & Europe Reproductive Genetics Analysis, Opportunity and Forecast, By Application, 2016-2032
- 3.6.1. North America & Europe Reproductive Genetics Analysis by Application: Introduction
- 3.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Application, 2016-2032
- 3.6.3. Aneuploidy
- 3.6.4. Structural Chromosomal Abnormality
- 3.6.5. Single Gene Disorder
- 3.6.6. Other Applications
- 4. North America Reproductive Genetics Analysis, Opportunity and Forecast, 2016-2032
- 4.1. North America Reproductive Genetics Analysis, 2016-2021
- 4.2. North America Reproductive Genetics Opportunity and Forecast, 2023-2032
- 4.3. North America Reproductive Genetics Analysis, Opportunity, and Forecast, By Procedure Type, 2016-2032
- 4.3.1. North America Reproductive Genetics Analysis by Procedure Type: Introduction
- 4.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Procedure Type, 2016-2032
- 4.3.3. Carrier Screening
- 4.3.3.1. Carrier Screening1
- 4.3.3.2. Carrier Screening2
- 4.3.4. Pre-Natal Screening
- 4.3.5. Pre-Implantation Genetic Testing
- 4.3.6. Infertility Genetic Testing
- 4.4. North America Reproductive Genetics Analysis, Opportunity, and Forecast, By Product Type, 2016-2032
- 4.4.1. North America Reproductive Genetics Analysis by Product Type: Introduction
- 4.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product Type, 2016-2032
- 4.4.3. Kits
- 4.4.4. Laboratory Developed Tests
- 4.4.5. Reagents & Consumables
- 4.5. North America Reproductive Genetics Analysis, Opportunity and Forecast, By Technology, 2016-2032
- 4.5.1. North America Reproductive Genetics Analysis by Technology: Introduction
- 4.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Technology, 2016-2032
- 4.5.3. Next Generation Sequencing
- 4.5.4. Polymerase Chain Reaction
- 4.5.5. In-Situ Hybridization
- 4.5.6. Microarray
- 4.6. North America Reproductive Genetics Analysis, Opportunity, and Forecast, By Application, 2016-2032
- 4.6.1. North America Reproductive Genetics Analysis by Application: Introduction
- 4.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Application, 2016-2032
- 4.6.3. Aneuploidy
- 4.6.4. Structural Chromosomal Abnormality
- 4.6.5. Single Gene Disorder
- 4.6.6. Other Applications
- 4.7. North America Reproductive Genetics Analysis, Opportunity and Forecast, By Country, 2016-2032
- 4.7.1. North America Reproductive Genetics Analysis by Country: Introduction
- 4.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country, 2016-2032
- 4.7.2.1. The U.S.
- 4.7.2.2. Canada
- 4.7.2.3. Mexico
- 5. Europe Reproductive Genetics Analysis, Opportunity and Forecast, 2016-2032
- 5.1. Europe Reproductive Genetics Analysis, 2016-2021
- 5.2. Europe Reproductive Genetics Opportunity and Forecast, 2023-2032
- 5.3. Europe Reproductive Genetics Analysis, Opportunity, and Forecast, By Procedure Type, 2016-2032
- 5.3.1. Europe Reproductive Genetics Analysis by Procedure Type: Introduction
- 5.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Procedure Type, 2016-2032
- 5.3.3. Carrier Screening
- 5.3.3.1. Carrier Screening1
- 5.3.3.2. Carrier Screening2
- 5.3.4. Pre-Natal Screening
- 5.3.5. Pre-Implantation Genetic Testing
- 5.3.6. Infertility Genetic Testing
- 5.4. Europe Reproductive Genetics Analysis, Opportunity, and Forecast, By Product Type, 2016-2032
- 5.4.1. Europe Reproductive Genetics Analysis by Product Type: Introduction
- 5.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product Type, 2016-2032
- 5.4.3. Kits
- 5.4.4. Laboratory Developed Tests
- 5.4.5. Reagents & Consumables
- 5.5. Europe Reproductive Genetics Analysis, Opportunity and Forecast, By Technology, 2016-2032
- 5.5.1. Europe Reproductive Genetics Analysis by Technology: Introduction
- 5.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Technology, 2016-2032
- 5.5.3. Next Generation Sequencing
- 5.5.4. Polymerase Chain Reaction
- 5.5.5. In-Situ Hybridization
- 5.5.6. Microarray
- 5.6. Europe Reproductive Genetics Analysis, Opportunity, and Forecast, By Application, 2016-2032
- 5.6.1. Europe Reproductive Genetics Analysis by Application: Introduction
- 5.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Application, 2016-2032
- 5.6.3. Aneuploidy
- 5.6.4. Structural Chromosomal Abnormality
- 5.6.5. Single Gene Disorder
- 5.6.6. Other Applications
- 5.7. Europe Reproductive Genetics Analysis, Opportunity and Forecast, By Country, 2016-2032
- 5.7.1. Europe Reproductive Genetics Analysis by Country: Introduction
- 5.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country, 2016-2032
- 5.7.2.1. U.K.
- 5.7.2.2. Germany
- 5.7.2.3. France
- 5.7.2.4. Spain
- 5.7.2.5. Italy
- 5.7.2.6. Russia
- 5.7.2.7. Rest of Europe
- 6. North America & Europe Reproductive Genetics Analysis, Opportunity and Forecast, By Region, 2016-2032
- 6.1. North America & Europe Reproductive Genetics Analysis by Region: Introduction
- 6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Region, 2016-2032
- 6.2.1. North America
- 6.2.2. Europe
- 7. North America & Europe Reproductive Genetics Competitive Landscape, Market Share Analysis, and Company Profiles
- 7.1. Market Share Analysis
- 7.2. Company Profiles
- 7.3. Agilent Technologies Inc.
- 7.3.1. Company Overview
- 7.3.2. Financial Highlights
- 7.3.3. Product Portfolio
- 7.3.4. SWOT Analysis
- 7.3.5. Key Strategies and Developments
- 7.4. BGI, CENTOGENE AG
- 7.4.1. Company Overview
- 7.4.2. Financial Highlights
- 7.4.3. Product Portfolio
- 7.4.4. SWOT Analysis
- 7.4.5. Key Strategies and Developments
- 7.5. Fulgent Genetics Inc.
- 7.5.1. Company Overview
- 7.5.2. Financial Highlights
- 7.5.3. Product Portfolio
- 7.5.4. SWOT Analysis
- 7.5.5. Key Strategies and Developments
- 7.6. F. Hoffmann-La Roche Ltd
- 7.6.1. Company Overview
- 7.6.2. Financial Highlights
- 7.6.3. Product Portfolio
- 7.6.4. SWOT Analysis
- 7.6.5. Key Strategies and Developments
- 7.7. Igenomix
- 7.7.1. Company Overview
- 7.7.2. Financial Highlights
- 7.7.3. Product Portfolio
- 7.7.4. SWOT Analysis
- 7.7.5. Key Strategies and Developments
- 7.8. Illumina Inc.
- 7.8.1. Company Overview
- 7.8.2. Financial Highlights
- 7.8.3. Product Portfolio
- 7.8.4. SWOT Analysis
- 7.8.5. Key Strategies and Developments
- 7.9. Invitae Corporation
- 7.9.1. Company Overview
- 7.9.2. Financial Highlights
- 7.9.3. Product Portfolio
- 7.9.4. SWOT Analysis
- 7.9.5. Key Strategies and Developments
- 7.10. Laboratory Corporation of America Holdings
- 7.10.1. Company Overview
- 7.10.2. Financial Highlights
- 7.10.3. Product Portfolio
- 7.10.4. SWOT Analysis
- 7.10.5. Key Strategies and Developments
- 7.11. PerkinElmer Inc.
- 7.11.1. Company Overview
- 7.11.2. Financial Highlights
- 7.11.3. Product Portfolio
- 7.11.4. SWOT Analysis
- 7.11.5. Key Strategies and Developments
- 7.12. Myriad Genetics Inc.
- 7.12.1. Company Overview
- 7.12.2. Financial Highlights
- 7.12.3. Product Portfolio
- 7.12.4. SWOT Analysis
- 7.12.5. Key Strategies and Developments
- 7.13. OPKO Health Inc.
- 7.13.1. Company Overview
- 7.13.2. Financial Highlights
- 7.13.3. Product Portfolio
- 7.13.4. SWOT Analysis
- 7.13.5. Key Strategies and Developments
- 7.14. Quest Diagnostics
- 7.14.1. Company Overview
- 7.14.2. Financial Highlights
- 7.14.3. Product Portfolio
- 7.14.4. SWOT Analysis
- 7.14.5. Key Strategies and Developments
- 7.15. QIAGEN N.V.
- 7.15.1. Company Overview
- 7.15.2. Financial Highlights
- 7.15.3. Product Portfolio
- 7.15.4. SWOT Analysis
- 7.15.5. Key Strategies and Developments
- 7.16. Thermo Fisher Scientific Inc.
- 7.16.1. Company Overview
- 7.16.2. Financial Highlights
- 7.16.3. Product Portfolio
- 7.16.4. SWOT Analysis
- 7.16.5. Key Strategies and Developments
- 8. Assumptions and Acronyms
- 9. Research Methodology
- 10. Contact
- List of Figures
- Figure 1: North America & Europe Reproductive Genetics Revenue (US$ Mn) Market Share by Procedure Type in 2022
- Figure 2: North America & Europe Reproductive Genetics Market Attractiveness Analysis by Procedure Type, 2016-2032
- Figure 3: North America & Europe Reproductive Genetics Revenue (US$ Mn) Market Share by Product Type in 2022
- Figure 4: North America & Europe Reproductive Genetics Market Attractiveness Analysis by Product Type, 2016-2032
- Figure 5: North America & Europe Reproductive Genetics Revenue (US$ Mn) Market Share by Technology in 2022
- Figure 6: North America & Europe Reproductive Genetics Market Attractiveness Analysis by Technology, 2016-2032
- Figure 7: North America & Europe Reproductive Genetics Revenue (US$ Mn) Market Share by Application in 2022
- Figure 8: North America & Europe Reproductive Genetics Market Attractiveness Analysis by Application, 2016-2032
- Figure 9: North America & Europe Reproductive Genetics Revenue (US$ Mn) Market Share by Region in 2022
- Figure 10: North America & Europe Reproductive Genetics Market Attractiveness Analysis by Region, 2016-2032
- Figure 11: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) (2016-2032)
- Figure 12: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Region (2016-2032)
- Figure 13: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Procedure Type (2016-2032)
- Figure 14: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
- Figure 15: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
- Figure 16: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Application (2016-2032)
- Figure 17: North America & Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
- Figure 18: North America & Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Procedure Type (2016-2032)
- Figure 19: North America & Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
- Figure 20: North America & Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
- Figure 21: North America & Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
- Figure 22: North America & Europe Reproductive Genetics Market Share Comparison by Region (2016-2032)
- Figure 23: North America & Europe Reproductive Genetics Market Share Comparison by Procedure Type (2016-2032)
- Figure 24: North America & Europe Reproductive Genetics Market Share Comparison by Product Type (2016-2032)
- Figure 25: North America & Europe Reproductive Genetics Market Share Comparison by Technology (2016-2032)
- Figure 26: North America & Europe Reproductive Genetics Market Share Comparison by Application (2016-2032)
- Figure 27: North America Reproductive Genetics Revenue (US$ Mn) Market Share by Procedure Type 2022
- Figure 28: North America Reproductive Genetics Market Attractiveness Analysis by Procedure Type, 2016-2032
- Figure 29: North America Reproductive Genetics Revenue (US$ Mn) Market Share by Product Type in 2022
- Figure 30: North America Reproductive Genetics Market Attractiveness Analysis by Product Type, 2016-2032
- Figure 31: North America Reproductive Genetics Revenue (US$ Mn) Market Share by Technology in 2022
- Figure 32: North America Reproductive Genetics Market Attractiveness Analysis by Technology, 2016-2032
- Figure 33: North America Reproductive Genetics Revenue (US$ Mn) Market Share by Application in 2022
- Figure 34: North America Reproductive Genetics Market Attractiveness Analysis by Application, 2016-2032
- Figure 35: North America Reproductive Genetics Revenue (US$ Mn) Market Share by Country in 2022
- Figure 36: North America Reproductive Genetics Market Attractiveness Analysis by Country, 2016-2032
- Figure 37: North America Reproductive Genetics Market Revenue (US$ Mn) (2016-2032)
- Figure 38: North America Reproductive Genetics Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 39: North America Reproductive Genetics Market Revenue (US$ Mn) Comparison by Procedure Type (2016-2032)
- Figure 40: North America Reproductive Genetics Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
- Figure 41: North America Reproductive Genetics Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
- Figure 42: North America Reproductive Genetics Market Revenue (US$ Mn) Comparison by Application (2016-2032)
- Figure 43: North America Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 44: North America Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Procedure Type (2016-2032)
- Figure 45: North America Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
- Figure 46: North America Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
- Figure 47: North America Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
- Figure 48: North America Reproductive Genetics Market Share Comparison by Country (2016-2032)
- Figure 49: North America Reproductive Genetics Market Share Comparison by Procedure Type (2016-2032)
- Figure 50: North America Reproductive Genetics Market Share Comparison by Product Type (2016-2032)
- Figure 51: North America Reproductive Genetics Market Share Comparison by Technology (2016-2032)
- Figure 52: North America Reproductive Genetics Market Share Comparison by Application (2016-2032)
- Figure 53: Europe Reproductive Genetics Revenue (US$ Mn) Market Share by Procedure Type in 2022
- Figure 54: Europe Reproductive Genetics Market Attractiveness Analysis by Procedure Type, 2016-2032
- Figure 55: Europe Reproductive Genetics Revenue (US$ Mn) Market Share by Product Type in 2022
- Figure 56: Europe Reproductive Genetics Market Attractiveness Analysis by Product Type, 2016-2032
- Figure 57: Europe Reproductive Genetics Revenue (US$ Mn) Market Share by Technology in 2022
- Figure 58: Europe Reproductive Genetics Market Attractiveness Analysis by Technology, 2016-2032
- Figure 59: Europe Reproductive Genetics Revenue (US$ Mn) Market Share by Application in 2022
- Figure 60: Europe Reproductive Genetics Market Attractiveness Analysis by Application, 2016-2032
- Figure 61: Europe Reproductive Genetics Revenue (US$ Mn) Market Share by Country in 2022
- Figure 62: Europe Reproductive Genetics Market Attractiveness Analysis by Country, 2016-2032
- Figure 63: Europe Reproductive Genetics Market Revenue (US$ Mn) (2016-2032)
- Figure 64: Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 65: Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Procedure Type (2016-2032)
- Figure 66: Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
- Figure 67: Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
- Figure 68: Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Application (2016-2032)
- Figure 69: Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 70: Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Procedure Type (2016-2032)
- Figure 71: Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
- Figure 72: Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
- Figure 73: Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
- Figure 74: Europe Reproductive Genetics Market Share Comparison by Country (2016-2032)
- Figure 75: Europe Reproductive Genetics Market Share Comparison by Procedure Type (2016-2032)
- Figure 76: Europe Reproductive Genetics Market Share Comparison by Product Type (2016-2032)
- Figure 77: Europe Reproductive Genetics Market Share Comparison by Technology (2016-2032)
- Figure 78: Europe Reproductive Genetics Market Share Comparison by Application (2016-2032)
- List of Tables
- Table 1: North America & Europe Reproductive Genetics Market Comparison by Procedure Type (2016-2032)
- Table 2: North America & Europe Reproductive Genetics Market Comparison by Product Type (2016-2032)
- Table 3: North America & Europe Reproductive Genetics Market Comparison by Technology (2016-2032)
- Table 4: North America & Europe Reproductive Genetics Market Comparison by Application (2016-2032)
- Table 5: North America & Europe Reproductive Genetics Revenue (US$ Mn) Comparison by Region (2016-2032)
- Table 6: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) (2016-2032)
- Table 7: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Region (2016-2032)
- Table 8: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Procedure Type (2016-2032)
- Table 9: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
- Table 10: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
- Table 11: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Application (2016-2032)
- Table 12: North America & Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
- Table 13: North America & Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Procedure Type (2016-2032)
- Table 14: North America & Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
- Table 15: North America & Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
- Table 16: North America & Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
- Table 17: North America & Europe Reproductive Genetics Market Share Comparison by Region (2016-2032)
- Table 18: North America & Europe Reproductive Genetics Market Share Comparison by Procedure Type (2016-2032)
- Table 19: North America & Europe Reproductive Genetics Market Share Comparison by Product Type (2016-2032)
- Table 20: North America & Europe Reproductive Genetics Market Share Comparison by Technology (2016-2032)
- Table 21: North America & Europe Reproductive Genetics Market Share Comparison by Application (2016-2032)
- Table 22: North America Reproductive Genetics Market Comparison by Product Type (2016-2032)
- Table 23: North America Reproductive Genetics Market Comparison by Technology (2016-2032)
- Table 24: North America Reproductive Genetics Market Comparison by Application (2016-2032)
- Table 25: North America Reproductive Genetics Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 26: North America Reproductive Genetics Market Revenue (US$ Mn) (2016-2032)
- Table 27: North America Reproductive Genetics Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 28: North America Reproductive Genetics Market Revenue (US$ Mn) Comparison by Procedure Type (2016-2032)
- Table 29: North America Reproductive Genetics Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
- Table 30: North America Reproductive Genetics Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
- Table 31: North America Reproductive Genetics Market Revenue (US$ Mn) Comparison by Application (2016-2032)
- Table 32: North America Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 33: North America Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Procedure Type (2016-2032)
- Table 34: North America Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
- Table 35: North America Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
- Table 36: North America Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
- Table 37: North America Reproductive Genetics Market Share Comparison by Country (2016-2032)
- Table 38: North America Reproductive Genetics Market Share Comparison by Procedure Type (2016-2032)
- Table 39: North America Reproductive Genetics Market Share Comparison by Product Type (2016-2032)
- Table 40: North America Reproductive Genetics Market Share Comparison by Technology (2016-2032)
- Table 41: North America Reproductive Genetics Market Share Comparison by Application (2016-2032)
- Table 42: Europe Reproductive Genetics Market Comparison by Procedure Type (2016-2032)
- Table 43: Europe Reproductive Genetics Market Comparison by Product Type (2016-2032)
- Table 44: Europe Reproductive Genetics Market Comparison by Technology (2016-2032)
- Table 45: Europe Reproductive Genetics Market Comparison by Application (2016-2032)
- Table 46: Europe Reproductive Genetics Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 47: Europe Reproductive Genetics Market Revenue (US$ Mn) (2016-2032)
- Table 48: Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 49: Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Procedure Type (2016-2032)
- Table 50: Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
- Table 51: Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
- Table 52: Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Application (2016-2032)
- Table 53: Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 54: Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Procedure Type (2016-2032)
- Table 55: Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
- Table 56: Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
- Table 57: Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
- Table 58: Europe Reproductive Genetics Market Share Comparison by Country (2016-2032)
- Table 59: Europe Reproductive Genetics Market Share Comparison by Procedure Type (2016-2032)
- Table 60: Europe Reproductive Genetics Market Share Comparison by Product Type (2016-2032)
- Table 61: Europe Reproductive Genetics Market Share Comparison by Technology (2016-2032)
- Table 62: Europe Reproductive Genetics Market Share Comparison by Application (2016-2032)
- 1. Executive Summary
- Invitae Corporation
- Laboratory Corporation of America Holdings
- PerkinElmer, Inc.
- Myriad Genetics, Inc.
- OPKO Health, Inc.
- Quest Diagnostics
- QIAGEN N.V.
- Thermo Fisher Scientific Company Profile
- Agilent Technologies, Inc.
- BGI
- CENTOGENE AG
- Fulgent Genetics, Inc.
- F. Hoffmann-La Roche Ltd
- Igenomix, Illumina, Inc.
- settingsSettings
Our Clients
- 84850
- Feb 2024
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible| Single User $6,000 $3,999 USD / per unit save 24% | Multi User $8,000 $5,999 USD / per unit save 28% | Corporate User $10,000 $6,999 USD / per unit save 32% | |
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
